Skip to content
PaperFren

Can ferritin flag deadly macrophage-like sepsis?

Open paper intelligence

In 5,121 Greek patients with infection and SIRS, macrophage activation-like syndrome (MALS) occurred in ~4% and independently predicted 10-day death; ferritin above 4420 ng/ml marked ~66% 28-day mortality.

Source

Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis

Kyriazopoulou E, Leventogiannis K, Norrby-Teglund A, et al. · BMC medicine · 2017

doi.org/10.1186/s12916-017-0930-5Read the full paper ↗164 citationscc by

Study at a glance

Design
Cohort — Prospective Greek sepsis cohorts (test n=3417, validation n=1704) plus a Swedish ferritin-validation cohort (n=109) classifying macrophage activation-like syndrome (MALS)
N
N=5121 · 3417 test + 1704 validation patients with infection and SIRS; ferritin repeated on day 3 in 747; Swedish cohort n=109
Population
Adults with infection plus SIRS enrolled by the Hellenic Sepsis Study Group (plus an independent Swedish sepsis cohort)
Outcome
MALS frequency, 10-day mortality, and ferritin as a diagnostic/prognostic biomarker

Structured fields used in claim comparison tables when every cited study has a complete layer.

What they did

Assigned patients to test (n=3417) and validation (n=1704) cohorts, defined MALS by HScore and/or DIC plus hepatobiliary dysfunction, measured ferritin and cytokines, and checked 10-day mortality; ferritin was repeated on day 3 in 747 patients and in 109 Swedish patients.

What they found

MALS frequency was 3.7% (test) and 4.3% (validation). Ferritin >4420 ng/ml had >97% specificity for MALS and 66.7%/66% 28-day mortality (OR 4.07 in the test cohort). A <15% day-3 ferritin drop had >90% sensitivity for 10-day death.

The limits

What it doesn't show

This observational classification does not prove that treating high-ferritin MALS (e.g., with anakinra) saves lives; HScore was modified without bone-marrow hemophagocytosis, so MALS is not identical to classic MAS.

Key terms

MALS
Macrophage activation-like syndrome: sepsis with MAS/HLH-like hyperinflammation, diagnosed here by HScore and/or DIC+HBD.
Ferritin
Iron-storage protein; serum levels >4420 ng/ml were proposed as a high-specificity MALS biomarker.
HScore
Hemophagocytic syndrome score used (without bone-marrow points) as one MALS criterion.
DIC
Disseminated intravascular coagulation; with hepatobiliary dysfunction, one MALS definition.
Anakinra
IL-1 receptor antagonist previously linked in a post-hoc RCT subset to better survival in DIC+HBD sepsis.
sCD163
Soluble macrophage marker that rose with hyperferritinemia, supporting macrophage activation.

Flashcards

1 / 10

Research intelligence for this paper

See its role on concept claims, tensions it is part of, placement history, and related discoveries.

Open paper intelligence

Quiz yourself

1 / 5

MALS frequency in the test cohort was about:

Common questions

How common was MALS?

3.7% of the test cohort and 4.3% of the validation cohort.

What ferritin cutoff did they propose?

Above 4420 ng/ml, with >97% specificity for MALS.

How deadly was that cutoff?

About 66–66.7% died by day 28; 10-day mortality was ~45%.

What day-3 change was ominous?

Less than a 15% ferritin decrease, >90% sensitive for 10-day death.

More on Critical care